Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Mainz Biomed N.V’s stock clocked out at $1.36, up 4.62% from its previous closing price of $1.3. In other words, the price has increased by $4.62 from its previous closing price. On the day, 1.08 million shares were traded. MYNZ stock price reached its highest trading level at $1.659 during the session, while it also had its lowest trading level at $1.255.
Ratios:
To gain a deeper understanding of MYNZ’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.43 and its Current Ratio is at 0.52. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Maxim Group on February 14, 2025, initiated with a Buy rating and assigned the stock a target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MYNZ now has a Market Capitalization of 7361480 and an Enterprise Value of 6747458. Its current Enterprise Value per Revenue stands at 10.224 whereas that against EBITDA is -0.418.
Stock Price History:
The Beta on a monthly basis for MYNZ is 0.26, which has changed by 4.2 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, MYNZ has reached a high of $14.39, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -12.16%, while the 200-Day Moving Average is calculated to be -49.79%.
Shares Statistics:
It appears that MYNZ traded 225.47K shares on average per day over the past three months and 96210 shares per day over the past ten days. A total of 5.41M shares are outstanding, with a floating share count of 5.23M. Insiders hold about 3.35% of the company’s shares, while institutions hold 7.13% stake in the company. Shares short for MYNZ as of 1761868800 were 36944 with a Short Ratio of 0.16, compared to 1759190400 on 89503. Therefore, it implies a Short% of Shares Outstanding of 36944 and a Short% of Float of 0.69.
Earnings Estimates
Analysts are recommending an EPS of between -$2.86 and -$2.86 for the fiscal current year, implying an average EPS of -$2.86. EPS for the following year is -$1.35, with 1.0 analysts recommending between -$1.35 and -$1.35.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for MYNZ’s current fiscal year. The highest revenue estimate was $957k, while the lowest revenue estimate was $957k, resulting in an average revenue estimate of $957k. In the same quarter a year ago, actual revenue was $893.99kBased on 1 analysts’ estimates, the company’s revenue will be $918k in the next fiscal year. The high estimate is $918k and the low estimate is $918k.
